We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$70.5B
1-Year Est. Return
36%
This Fund
S&P 500
This Quarter
Est. Return
+8.62%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$32.2B
AUM Growth
-$282M
(-0.87%)
Cap. Flow
-$1.84B
Cap. Flow
% of AUM
-5.7%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
2,410
New
656
Increased
561
Reduced
740
Closed
337
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ericsson
ERIC
|
+$279M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$254M |
| 3 |
Citigroup
C
|
+$193M |
| 4 |
Fortinet
FTNT
|
+$143M |
| 5 |
Infosys
INFY
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$406M |
| 2 |
Pinduoduo
PDD
|
+$382M |
| 3 |
Amazon
AMZN
|
+$380M |
| 4 |
Meta Platforms (Facebook)
META
|
+$259M |
| 5 |
CRH
CRH
|
+$247M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.81% |
| 2 | Financials | 16.09% |
| 3 | Communication Services | 9.47% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Healthcare | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
1801
DELISTED
Avadel Pharmaceuticals
AVDL
| $47K | ﹤0.01% |
+3,639
| New | +$55.4K |
|
1802
Corteva
CTVA
$50.6B
| $47K | ﹤0.01% |
812
-18,867
| -96% | -$1.03M |
|
1803
Immunome
IMNM
$2.93B
| $47K | ﹤0.01% |
+3,237
| New | +$46K |
|
1804
John Wiley & Sons Class A
WLY
$2.58B
| $47K | ﹤0.01% |
985
-33,918
| -97% | -$1.56M |
|
1805
Acumen Pharmaceuticals
ABOS
$178M
| $46K | ﹤0.01% |
+18,643
| New | +$50.6K |
|
1806
C3.ai
AI
$1.62B
| $46K | ﹤0.01% |
+1,924
| New | +$48.9K |
|
1807
Cars.com
CARS
$639M
| $46K | ﹤0.01% |
+2,781
| New | +$50.7K |
|
1808
CG Oncology
CGON
$6.75B
| $46K | ﹤0.01% |
+1,227
| New | +$43K |
|
1809
Digital Realty Trust
DLR
$70.6B
| $46K | ﹤0.01% |
285
-25,376
| -99% | -$3.89M |
|
1810
Enliven Therapeutics
ELVN
$4.27B
| $46K | ﹤0.01% |
+1,825
| New | +$42.3K |
|
1811
Grindr
GRND
$2.86B
| $46K | ﹤0.01% |
+3,856
| New | +$45.7K |
|
1812
Hims & Hers Health
HIMS
$7.28B
| $46K | ﹤0.01% |
+2,516
| New | +$45K |
|
1813
ImmunityBio
IBRX
$8.03B
| $46K | ﹤0.01% |
+12,432
| New | +$57.5K |
|
|
MRSN
1814
DELISTED
Mersana Therapeutics
MRSN
| $46K | ﹤0.01% |
976
-1,884
| -66% | -$83.1K |
|
1815
Minerva Neurosciences
NERV
$218M
| $46K | ﹤0.01% |
17,416
-7
| -0% | -$20 |
|
1816
Pitney Bowes
PBI
$2.31B
| $46K | ﹤0.01% |
+6,595
| New | +$44.5K |
|
1817
Virgin Galactic
SPCE
$492M
| $46K | ﹤0.01% |
+7,637
| New | +$51K |
|
1818
Triumph Financial Inc
TFIN
$1.81B
| $46K | ﹤0.01% |
+584
| New | +$48.8K |
|
|
TRIB
1819
Trinity Biotech
TRIB
$9.22M
| $46K | ﹤0.01% |
1,395
-1,009
| -42% | -$68.2K |
|
1820
Wintrust Financial
WTFC
$10.8B
| $46K | ﹤0.01% |
433
| – | – |
|
1821
AN2 Therapeutics
ANTX
$218M
| $45K | ﹤0.01% |
42,335
-44,613
| -51% | -$77.4K |
|
1822
BILL Holdings
BILL
$4.98B
| $45K | ﹤0.01% |
864
-41,075
| -98% | -$2.11M |
|
1823
Novavax
NVAX
$1.3B
| $45K | ﹤0.01% |
+3,602
| New | +$46.5K |
|
1824
StoneX
SNEX
$7.78B
| $45K | ﹤0.01% |
+1,870
| New | +$44.1K |
|
1825
Teradata
TDC
$2.54B
| $45K | ﹤0.01% |
1,499
-10,616
| -88% | -$317K |
|
Similar funds
Acadian Asset Management's Q3 2024 Portfolio in Review
As of Q3 2024, Acadian Asset Management held 2,410 positions worth $32.2B, down 0.87% from $32.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Acadian Asset Management withdrew a net $1.84B in Q3 2024, closing 337 positions and reducing 740 holdings. Its most notable exit was Kanzhun, an estimated $20.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 35% a quarter earlier, followed by Financials and Communication Services.
Against the trend, Acadian Asset Management opened a new position in UL Solutions worth $45.8M.
- Acadian Asset Management's largest Q3 2024 buy was UL Solutions: 928,296 shares worth $45.8M.
- Acadian Asset Management added most to Ericsson in Q3 2024, an estimated $279M increase.
- Acadian Asset Management's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $406M.
- Acadian Asset Management fully exited Kanzhun in Q3 2024, selling an estimated $20.3M.
- Acadian Asset Management's ten largest holdings make up 24% of its $32.2B portfolio in Q3 2024.
- Acadian Asset Management opened 656 new positions and closed 337 in Q3 2024.
- Acadian Asset Management's portfolio value fell 0.87% quarter-over-quarter to $32.2B.
Based on Acadian Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.